Skip to main content
. 2007 Jul 31;104(32):13140–13145. doi: 10.1073/pnas.0705926104

Table 2.

Binding of monoclonal antibodies to selected gB mutants.

Region* Position of insertion Monoclonal antibodies
II-105 I-84-5 II-125-4 I-I-7 I-144-2 I-252-4
N terminus P80 +++ +++ +++ +++ +++ ++
Domain I I185 +++ +++ +++ +++ ++ +++
E187 +++ +++ +++ +++ ++ ++
A261 +++ +++ +++ +++ ++ ++
Domain II D408 +++ +++ +++ ++ ++ ++
Disordered R470 +++ +++ +++ +++ +++ +++
Linker 2 I495 +++ +++ +++ ++ ++ +++
T497 +++ +++ +++ +++ +++ +++
Domain III D663 +++ +++ +++ +++ +++ ++
T665 + + + ++
V667 +
Domain V I671 +++ +++ ++ +++ + ++
L673 +++ + + +
A725 +++ +++ +++ +++ +++ +++
Membrane-proximal A730 +++ +++ +++ +++ +++ +++
F732 +++ +++ +++ +++ +++ +++
M742 +++ +++ +++ +++ +++ +++
C-terminal tail T868 ++ +++ + ++ + +++
N886 ++ ++ ++ ++ ++ ++

*From Heldwein et al. (12).

List includes mutants for which rabbit antiserum R74 binds at >25% of WT gB levels by CELISA.

CELISA data were normalized to the reactivity of each mAb to WT gB. The normalized values for each mAb were then compared with values obtained using rabbit antiserum R74 for each gB mutant to determine relative changes in reactivity. The symbols represent >80% (+++), 50–80% (++), 20–50% (+), and <20% (–) reactivity of each mAb compared to R74 values for each gB mutant.